Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Endo And Mallinckrodt Plan To Merge - And Spin Off Generics Business
CEO Siggi Olafsson Will Lead The Combined Firm
Mar 14 2025
•
By
Joseph Haas
The Endo/Mallinckrodt combination is valued at an estimated $6.7bn • Source: Shutterstock
More from Deals
More from Products